Corporate News     04-Oct-21
Biocon launches Everolimus tablets in the US market
Biocon today announced the launch of Everolimus tablets, a generic version of Afinitor®, in the US. Everolimus tablets have been introduced in four strengths of 2.5mg, 5mg, 7.5mg and 10mg, with the 10 mg tablet being a ‘day-1' generic launch.

Everolimus (Afinitor®) is a prescription medication that is used to treat certain types of cancers and tumours.

The commercial launch of Everolimus follows an US FDA approval in February 2021.

Previous News
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Biocon signs exclusive licensing and supply agreement with Handok
 ( Corporate News - 24-May-24   09:06 )
  Biocon consolidated net profit rises 167.80% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   17:28 )
  USFDA classifies inspection of Biocon Biologic's Malaysian unit as 'OAI'
 ( Corporate News - 18-Oct-23   09:28 )
  Biocon gets US FDA approval for market generic version of anti-cancer drug
 ( Hot Pursuit - 07-Feb-24   09:35 )
  Biocon enters Dow Jones Sustainability Index for Emerging Markets
 ( Corporate News - 01-Dec-21   17:21 )
  Biocon records turnaround PAT of Rs 660 cr in Q3
 ( Hot Pursuit - 09-Feb-24   14:12 )
  Biocon Ltd drops for fifth straight session
 ( Hot Pursuit - 22-Feb-22   13:35 )
  Biocon Ltd rises for third consecutive session
 ( Hot Pursuit - 24-Mar-22   13:05 )
  Biocon Ltd spurts 4.01%, rises for fifth straight session
 ( Hot Pursuit - 26-Apr-24   13:00 )
Other Stories
  Jyoti Structures to conduct board meeting
  06-Jul-24   09:35
  New Light Apparels to declare Quarterly Result
  06-Jul-24   09:34
  Geojit Financial Services to convene board meeting
  06-Jul-24   09:34
  VIP Clothing announces board meeting date
  06-Jul-24   09:34
  Elitecon Intl. to conduct board meeting
  06-Jul-24   09:34
  Gautam Gems to announce Quarterly Result
  06-Jul-24   09:34
  Everest Industries schedules AGM
  06-Jul-24   09:33
  Family Care Hospitals to conduct board meeting
  06-Jul-24   09:33
  Infomedia Press to declare Quarterly Result
  06-Jul-24   09:33
  Mishtann Foods to table results
  06-Jul-24   09:33
Back Top